New regulators of natural killer cell-mediated cytotoxicity
New regulators of natural killer cell-mediated cytotoxicity
批准号:
10370297
负责人:
Suzhao Li
金额:
$7.78万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-11 至 2024-02-29
关键词:
AllogenicApoptosisAreaBiological AssayCRISPR/Cas technologyCandidate Disease GeneCell DeathCell LineCell TherapyCell membraneCell physiologyCell-Mediated CytolysisCellsCessation of lifeClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesCytoplasmic GranulesDataData SetDevelopmentEffector CellExhibitsFundingGenesGenetic ScreeningGleanGoalsGranzymeHumanImmune System DiseasesImmune responseImmunologic Deficiency SyndromesIndividualInfectionInnate Immune SystemKnock-outKnowledgeLigandsLinkLymphocyteLysosomesMalignant NeoplasmsMediatingMembraneNatural Killer Cell toxicityNatural Killer CellsPathway interactionsPilot ProjectsPlayResearchResearch PersonnelResourcesSafetySerine ProteaseStructureTNF geneTNFSF6 geneTumor Necrosis Factor Ligand Superfamily Member 6VDAC1 geneWorkbasecancer immunotherapycell killingchronic infectiongenome editinggenome-widehuman diseaseimmunological synapseimprovedinnovationinsightnovel therapeuticsorgan transplant rejectionpathogenperforinprogramsreceptorresponsetransforming virus
中文摘要
项目摘要
自然杀伤(NK)细胞是先天免疫系统中的关键效应淋巴细胞。它们展现所
检测和清除转化细胞和病毒感染细胞的显著能力。NK细胞也是一个关键
在同种异体供体移植器官排斥反应中的作用。NK细胞介导的杀伤的不平衡是
与主要形式的人类疾病如癌症、慢性感染和免疫缺陷相关。到
为了提高基于NK细胞的疗法的疗效,关键是要确定控制NK细胞应答的基因。
靶细胞对NK细胞介导的杀伤。在我们的初步研究中,
来剖析NK样细胞系对靶细胞的杀伤。这些筛选分离出了已知的NK细胞杀伤调节因子,
大多数的命中先前与NK细胞功能无关。该试点项目的主要目标是
使用人原代NK细胞验证和表征这些候选基因。这些基因中的每一个都会
使用CRISPR基因组编辑在靶细胞中单独删除。然后我们将确定淘汰赛
NK细胞对原代NK细胞的杀伤有反应。一旦候选基因得到验证,我们将进一步表征
其在NK细胞介导的细胞毒作用中的作用和机制。该试点项目的成功完成将
大大拓宽了我们对NK细胞如何识别和杀死靶细胞的知识。从以下方面收集的见解
这项工作将有助于提高癌症和病原体感染免疫疗法的有效性和安全性。
英文摘要
PROJECT SUMMARY
Natural killer (NK) cells are key effector lymphocytes in the innate immune system. They exhibit the
remarkable abilities of detecting and eradicating transformed and virus-infected cells. NK cells also play a key
role in the rejection of transplanted organs from allogeneic donors. Imbalances in NK cell-mediated killing are
associated with major forms of human disease such as cancer, chronic infection, and immunodeficiency. To
improve the efficacy of NK cell-based therapies, it is critical to identify the genes controlling the response of
target cells to NK cell-mediated killing. In our preliminary studies, we performed genome-wide genetic screens
to dissect target cell killing by an NK-like cell line. The screens isolated known regulators of NK cell killing but
the majority of the hits were not previously linked to NK cell functions. The major goal of this pilot project is to
validate and characterize these candidate genes using human primary NK cells. Each of these genes will be
individually deleted in target cells using CRISPR genome editing. We will then determine how the knockout
cells respond to killing by primary NK cells. Once a candidate gene is validated, we will further characterize
its function and mechanism in NK cell-mediated cytotoxicity. Successful completion of this pilot project will
substantially broaden our knowledge of how NK cells recognize and kill target cells. Insights gleaned from
this work will help improve the efficacy and safety of immunotherapies for cancer and pathogen infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Outer membrane vesicles in macrophage inflammation and pyroptosis
-
批准号:10365997
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2021
-
负责人:Suzhao Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: